David R. Parkinson

Co-Founder, Director at Refuge Biotechnologies, Inc.

David R. Parkinson

David R. Parkinson

Co-Founder, Director at Refuge Biotechnologies, Inc.

Overview
Career Highlights

International Society for Biological Therapy of Cancer
Zyngenia, Inc.
ESSA Pharma, Inc.

RelSci Relationships

8464

Number of Boards

23

Birthday

1951

Age

70

Relationships
RelSci Relationships are individuals David R. Parkinson likely has professional access to. A relationship does not necessarily indicate a personal connection.

Co-Founder at Gossamer Bio, Inc.

Relationship likelihood: Strong

Co-Founder at 3SBio, Inc.

Relationship likelihood: Strong

Professor at University of British Columbia

Relationship likelihood: Strong

Co-Founder at Refuge Biotechnologies, Inc.

Relationship likelihood: Strong

Senior Vice President, General Manager, Executive Director at 3SBio, Inc.

Relationship likelihood: Strong

Co-Founder at The Multiple Myeloma Research Foundation, Inc.

Relationship likelihood: Strong

Co-Founder at The Multiple Myeloma Research Foundation, Inc.

Relationship likelihood: Strong

Founding Fellow at Biotechnology Study Center at New York University School of Medicine

Relationship likelihood: Strong

Chairman at Zyngenia, Inc.

Relationship likelihood: Strong

Co-Founder at Three Arch Partners

Relationship likelihood: Strong

Paths to David R. Parkinson
Potential Connections via
Relationship Science
You
David R. Parkinson
Co-Founder, Director at Refuge Biotechnologies, Inc.
Memberships
Member, National Cancer Policy Forum
Prior

The National Academy of Medicine (NAM), formerly called the Institute of Medicine (IoM), is an American nonprofit, non-governmental organization. The National Academy of Medicine is a part of the National Academies of Sciences, Engineering, and Medicine, along with the National Academy of Sciences (NAS), National Academy of Engineering (NAE), and the National Research Council (NRC). The National Academy of Medicine provides national advice on issues relating to biomedical science, medicine, and health, and serves as an adviser to the nation to improve health. It aims to provide unbiased, evidence-based, and authoritative information and advice concerning health and science policy to policy-makers, professionals, leaders in every sector of society, and the public at large. Operating outside the framework of the U.S. federal government, it relies on a volunteer workforce of scientists and other experts, operating under a formal peer-review system. As a national academy, new members of the organization are elected annually by current members, based on their distinguished and continuing achievements in a relevant field as well as for their willingness to participate actively.

President
Prior

International Society for Biological Therapy of Cancer is an American nonprofit company located in Milwaukee, WI, that operates as professional society of influential scientists, academicians, researchers, clinicians and government representatives.

Career History
President, Chief Executive Officer & Director
2016 - Current

ESSA Pharma, Inc. engages in the development of small molecule drugs for prostate cancer. It focuses on producing drugs which selectively block the amino-terminal domain (NTD) of the androgen receptor (AR), potentially overcoming the known AR-dependent resistance mechanisms of castration-resistant prostate cancer (CRPC), and providing CRPC patients with the potential for increased progression-free and overall survival. The company was founded by Marianne D. Sadar and Raymond J. Andersen on January 6, 2009 and is headquartered in Vancouver, Canada.

Co-Founder, Director
Current

Refuge Biotechnologies, Inc. develops therapeutic cells. It is leveraging gene engineering technologies known as CRISPR interference (CRISPRi) and CRISPR activation (CRISPRa) to develop therapeutic cells that are programmed to make decisions inside the patient’s body. The firms programs include RB-1916, RB-H21 and RB-M1. The company was founded by Stanley Qi, David R. Parkinson and Bing C. Wang and is headquartered in Menlo Park, CA.

Venture Advisor
Prior - 2016

New Enterprise Associates seeks invests in companies located across the globe. The firm targets companies operating in the fields of technology (software & services, systems, consumer & internet, energy), healthcare (biopharms, devices, services). The firm provides financing for seed, early and growth stage capital requirements.

Boards & Committees
Member, Scientific Advisory Board
2015 - Current

Cotinga Pharmaceuticals, Inc. is engaged in the development of therapeutics for the treatment of cancer and other unmet medical needs. It offers COTI-2 and COTI-219 pipelines. The COTI-2 pipeline targets gynecologic cancers and head and neck squamous cell carcinoma. The COTI-219 pipeline focuses on the treatment of lung, colorectal, pancreatic and thyroid cancers. The company was founded on October 13, 2006 and is headquartered in Toronto, Canada.

Director
2008 - 2010

Abbott Biotherapeutics Corp. engages in the identification and development of oncology therapeutics. The firm's products in development include Daclizumab, a monoclonal antibody in Phase IIb clinical studies that binds to the alpha chain of the interleukin-2 receptor on activated T cells; and Volociximab, a chimeric monoclonal antibody in Phase I clinical studies that inhibits the functional activity of a protein in activated endothelial cells. The company was founded in 2008 and is headquartered in Redwood City, CA.

Director
Prior

Multiple Myeloma Research Foundation, the mission of the MMRF is to accelerate the development of novel and combination treatments for patients with multiple myeloma by promoting and facilitating collaborative research between industry and academia. The MMRC is led by an exceptional Leadership Team, including a full scientific and clinical staff, which is headquartered in Norwalk, Conn

Director
Prior

Ontario Institute for Cancer Research provides research on the prevention, early detection, diagnosis, and treatment of cancer. It offers Innovation programs, like cancer stem cell, innovation in target validation, and smarter imaging, Technology programs, like drug discovery, genome technologies, informatics and bio-computing, imaging translation, and tranformative pathology, and Translation programs. The company was founded by Calvin R. Stiller in December 2005 and is headquartered in Toronto, Canada.

Chairman, Board of Directors
Prior

The Food and Drug Administration (FDA or USFDA) is an agency of the United States Department of Health and Human Services, one of the United States federal executive departments. The FDA is responsible for protecting and promoting public health through the regulation and supervision of food safety, tobacco products, dietary supplements, prescription and over-the-counter pharmaceutical drugs (medications), vaccines, biopharmaceuticals, blood transfusions, medical devices, electromagnetic radiation emitting devices (ERED), and veterinary products. The FDA also enforces other laws, notably Section 361 of the Public Health Service Act and associated regulations, many of which are not directly related to food or drugs. These include sanitation requirements on interstate travel and control of disease on products ranging from certain household pets to sperm donation for assisted reproduction. The FDA is led by the Commissioner of Food and Drugs, appointed by the President with the advice and consent of the Senate. The Commissioner reports to the Secretary of Health and Human Services. The 21st and current Commissioner is Dr. Margaret A. Hamburg. She has served as Commissioner since May 2009. The FDA has its headquarters in unincorporated White Oak, Maryland. The agency also has 223 field offices and 13 laboratories located throughout the 50 states, the United States Virgin Islands, and Puerto Rico. In 2008, the FDA started opening offices in foreign countries, including China, India, Costa Rica, Chile, Belgium, and the United Kingdom. In June 1906, President Theodore Roosevelt signed into law the Food and Drug Act, also known as the "Wiley Act" after its chief advocate Dr. Harvey Washington Wiley who riveted the country's and eventually congress's attention with public hygiene demonstrations. This act was the basis for the modern USFDA, being originally given the name of the Food, Drug, and Insecticide organization. The name eventually was shortened to the Food and Drug Administration (FDA) a few years later.

Political Donations
$1,000
2005

Former Senator from North Dakota

$500
2004

Senator from North Carolina

Transactions
Details Hidden

ESSA Pharma, Inc. raised money in a private placement transaction

Details Hidden

ESSA Pharma, Inc. raised money in a private placement transaction

Details Hidden

ESSA Pharma, Inc. raised money in a private placement transaction

Investments
Details Hidden

Refuge Biotechnologies, Inc. develops therapeutic cells. It is leveraging gene engineering technologies known as CRISPR interference (CRISPRi) and CRISPR activation (CRISPRa) to develop therapeutic cells that are programmed to make decisions inside the patient’s body. The firms programs include RB-1916, RB-H21 and RB-M1. The company was founded by Stanley Qi, David R. Parkinson and Bing C. Wang and is headquartered in Menlo Park, CA.

Public Holdings
Restricted data only for RelSci Professional users.
Events
Speaker
New York City, NY
4th Annual Partnering for Cures

Partnering for Cures is FasterCures' annual meeting that brings together diverse participants to discuss and solve the crucial issues facing the medical research world today. Partnering for Cures is structured with thought-provoking panels that host well-known speakers from the different sectors of the medical world; presenters from organizations that are boasting innovative approaches to the issues facing health; pro-bono, personalized advice from experts across medical research fields; and a unique partnering systems that allows conference participants to schedule meetings throughout the weekend to collaborate and create new approaches to save and improve lives.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by David R. Parkinson. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of David R. Parkinson's profile does not indicate a business or promotional relationship of any kind between RelSci and David R. Parkinson.